30 Apr Metabolic Surgery: a new approach for treatment of Type 2 Diabetes
Metabolic Surgery: a new approach for treatment of Type 2 Diabetes
Type 2 Diabetes is associated with complex metabolic dysfunctions, leading to increased morbidity, mortality, and cost. Although population-based efforts through lifestyle interventions are essential to prevent obesity and diabetes, people who develop this disease should have access to all effective treatment options.
Given its role in metabolic regulation, the GI tract constitutes a clinically and biologically meaningful target for the management of Type 2 Diabetes. Study has shown evidence that metabolic surgery can achieve excellent control over hyperglycemia and reduce other related cardiovascular risks.
There is now sufficient clinical and mechanistic evidence to support inclusion of metabolic surgery among anti diabetes interventions for people with TYPE 2 DIABETES and obesity. Use of BMI as a sole complementary criteria used to select candidates for bariatric surgery has to be developed to achieve a better patient selection algorithm for metabolic surgery.
Metabolic surgery should be a recommended option to treat TYPE 2 DIABETES in appropriate surgical candidates with following:
- BMI ≥40 kg/m2, regardless of the level of glycemic control
- BMI 35.0–39.9 kg/m with inadequately controlled hyperglycemia despite lifestyle and optimal medical therapy.
- BMI 30.0–34.9 kg/m2 and inadequately controlled hyperglycemia despite optimal medical treatment by either oral or injectable medications (including insulin).
- All BMI thresholds should be reconsidered depending on the ancestry of the patient. In Asian patient, the BMI values above should be reduced by 2.5 kg/m2.
according to guidelines for postoperative management of bariatric/metabolic surgery by national and international professional societies, patient long-term monitoring of micronutrient status, nutritional supplementation is essential, and support must be provided.
Metabolic surgery is a potentially cost-effective treatment option in obese patients with TYPE 2 DIABETES. The clinical community should work together with health care regulators to recognize metabolic surgery as an appropriate intervention for TYPE 2 DIABETES in people with obesity and to introduce appropriate reimbursement policies.
Till date, diabetes is poorly understood and medical treatment cannot claim a “Cure”. The aim is to put it in remission, defined as normal blood sugar levels and no need for diabetes medication. This means bringing glucose to normal levels and arresting the progression of the diabetic complications, thus giving the body a chance to repair the damage. In 2004, study in Journal of the American Medical Association (JAMA) of more than 22,000 people who underwent bariatric surgery showed the following:
- Diabetes was completely resolved or improved in 86% of patients.
- High blood lipids improved in 70% or more of patients.
- High blood pressure was resolved or improved in 78% of patients.
Why Choose Us for Metabolic Surgery/ Weight Loss Surgery
We at CODSILS are a team of professional surgeons, consultants, dieticians are committed to provide a healthier life to our patients through best patient care and support.
Dr. Amit is a known as one of the Best Bariatric and Metabolic Surgeon in India. He is the first one in North India to perform Loop duodenojejunal bypass with sleeve gastrectomy for Type 2 diabetes. Amit Garg is one of the best bariatric surgeon in North India with more than 1000 surgeries and has many international publications to his credit.
He is famous for his medical expertise in Chandigarh, Mohali, Ludhiana, Jallandhar and many other cities of the state. His surgical skills and diet control programs are pioneering in Punjab. Through his dedicated services in treatment of diabetes in Chandigarh, he has gained huge recognition as diabetes and weight loss doctor.